Health and Fitness Health and Fitness
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Medwell Capital to Adopt IFRS
[ Mon, Oct 03rd 2011 ] - Market Wire
IMRIS Announces Retirement of Chief Operating Officer
[ Mon, Oct 03rd 2011 ] - Market Wire
Allegiance Completes Private Placement Of 229,166 Common At $0.48 Per Share
Sun, October 2, 2011
[ Sun, Oct 02nd 2011 ] - Market Wire
HeartWare Reports Additional Clinical Data From B .. nued Access Patients at the 25th European Associa
Sat, October 1, 2011
[ Sat, Oct 01st 2011 ] - Market Wire
HealthSpring Unveils 2012 Medicare Advantage Plans
Fri, September 30, 2011
[ Fri, Sep 30th 2011 ] - Market Wire
Coventry Health Care Joins Forces with Walgreens, .. Part D Plan Available Across the Continental U.S
[ Fri, Sep 30th 2011 ] - Market Wire
Hologic Celebrates 10 Years of Providing Women wi .. nimally Invasive Solution for Their Heavy Periods
[ Fri, Sep 30th 2011 ] - Market Wire
ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA
[ Fri, Sep 30th 2011 ] - Market Wire
Dehaier Medical Appoints Interim Chief Financial Officer
[ Fri, Sep 30th 2011 ] - Market Wire
Sangamo BioSciences to Host Conference Call to Di .. m Phase 2b Trial of SB-509 in Diabetic Neuropathy
[ Fri, Sep 30th 2011 ] - Market Wire
AxoGen, Inc. Announces Completion of Merger, Name Change and Executive Team Changes
[ Fri, Sep 30th 2011 ] - Market Wire
Alliance HealthCare Services Announces Amendment .. t;; Receives Notice Regarding NYSE Listing
[ Fri, Sep 30th 2011 ] - Market Wire
Glancy Binkow & Goldberg LLP Continues Investigation of American Medical Alert Corp.
[ Fri, Sep 30th 2011 ] - Market Wire
Health Management Associates, Inc. Completes the .. alth Partners from Catholic Health Partners, Inc.
[ Fri, Sep 30th 2011 ] - Market Wire
Merck Announces New Data Analyses for VICTRELISa" .. ed at The American Association for the Study of L
[ Fri, Sep 30th 2011 ] - Market Wire
Vertex to Present New Data from Hepatitis C Development Program at AASLD Annual Meeting
[ Fri, Sep 30th 2011 ] - Market Wire
Reminding Seniors to Be Mindful of Medications
[ Fri, Sep 30th 2011 ] - Market Wire
Pfizer Reports Top-Line Results Of A Phase 3 Clin .. acy And Safety Of VFEND® (voriconazole) And ERAX
[ Fri, Sep 30th 2011 ] - Market Wire
Merck to Hold Third-Quarter 2011 Sales and Earnings Conference Call on October 28
[ Fri, Sep 30th 2011 ] - Market Wire
A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[ Fri, Sep 30th 2011 ] - Market Wire
ShangPharma to Attend Upcoming Investor Conferences in October
[ Fri, Sep 30th 2011 ] - Market Wire
Concord Medical Services Announces Share Repurchase Program
Thu, September 29, 2011
[ Thu, Sep 29th 2011 ] - Market Wire
Masimo Achieves New Milestonea"Ships One Millionth Oximeter
[ Thu, Sep 29th 2011 ] - Market Wire
Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial
[ Thu, Sep 29th 2011 ] - Market Wire
Geron Corporation Appoints John A. Scarlett as Chief Executive Officer and Director
[ Thu, Sep 29th 2011 ] - Market Wire
AstraZeneca Enters Into a Settlement Agreement wi .. ls regarding U.S. SEROQUEL XR® Patent Litigation
[ Thu, Sep 29th 2011 ] - Market Wire
Magellan Launches Behavioral Health Provider Locator App
[ Thu, Sep 29th 2011 ] - Market Wire
Biogen Idec bevordert Tony Kingsley tot hoofd van Global Commercial Operations
[ Thu, Sep 29th 2011 ] - Market Wire
Biogen Idec asciende a Tony Kingsley para dirigir las operaciones comerciales mundiales

Biogen Idec asciende a Tony Kingsley para dirigir las operaciones comerciales mundiales


Published on 2011-09-29 10:27:54 - Market Wire
  Print publication without navigation


WESTON, Mass.--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) ha anunciado que Tony Kingsley ha sido ascendido a Vicepresidente Ejecutivo de Operaciones Comerciales Mundiales, con efecto a partir del 7 de noviembre. Kingsley, de 48, supervisar el desarrollo y la ejecucin de las estrategias empresariales comerciales mundiales de Biogen Idec, bajo la supervisin directa de George A. Scangos, Ph.D, CEO de la empresa. Francesco Granata, de 60, que ha dirigido las operaciones comerciales mundiales desde principios de 2010, deja la empresa en busca de otras oportunidades, pero seguir en la empresa hasta finales de febrero para garantizar una transicin tranquila.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

Contributing Sources